Amir H. Lebastchi, MD

Assistant Professor of Urology at USC | Prostate Cancer | Urologic Oncology | Focal Therapy

[Amir H. Lebastchi, MD @AmirLebastchiMD]

@MUSC_UroOnc @LuisMedinaMD @PCFnews @muschollings Proud of you @LuisMedinaMD !

[BackTable Urology @_backtableUro]

A PSA under four can still be too high for a 45-year-old man. 📈

Prostate cancer biomarkers, MRI, and biopsy decisions, from numbers to next steps, with Dr. Amir Lebastchi of @KeckMedicineUSC and Dr. Ruchika Talwar (@RuchikaTalwarMD).

This podcast is supported by Cleveland Diagnostics.

Watch the full episode on the BackTable App: https://t.co/vJSWEmP9uO

#URO338 #ProstateCancer #Biomarkers #ProstateBiopsy #UrologicOncology #PSA @theNCI @AmerUrological

[Wei Phin Tan, MD, MHS, FACS @DrTanWP]

@AmirLebastchiMD (@USC_Urology) on surveillance after focal therapy: PSA, MRI, biopsy, PSMA, and retreatment triggers. He led the @FocalSociety Delphi consensus that standardized follow-up after partial gland ablation (Eur Urol 2020). Focal therapy is only as good as the follow-up. https://t.co/lHKiR7SZrC

[Amir H. Lebastchi, MD @AmirLebastchiMD]

It was a privilege to participate in the @FocalSociety meeting and share our experience in focal therapy for prostate cancer.

Proud to help train the next generation of urologists and advance the field responsibly in an evidence-based approach. @USC_Urology

[Sia Daneshmand, M.D. @siadaneshmand]

Congratulations Domenique Escobar for completing the #SUO fellowship. We are so proud of you. Congratulations for your appointment as Assistant Professor at @OHSUurology especially meaningful for me that is where I started my academic career. @USC_Urology @UroOnc Welcome Anas Tresh from @StanfordUrology and welcome to your clinical year @MichaelBasinMD @domesypantsx3 @AnneSchuckmanMD Amir Lebastchi.